KalVista Pharmaceuticals (KALV) Free Cash Flow (2018 - 2026)
KalVista Pharmaceuticals (KALV) free cash flow from Jul 31, 2018 to Mar 31, 2026. The TTM KalVista Pharmaceuticals (KALV) free cash flow is -$66M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
KalVista Pharmaceuticals (KALV) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -48.72% |
| 3 Years TTM | -6.67% |
| 5 Years TTM | +15.56% |
| All Time TTM | +6.88% |
Annual Free Cash Flow change of KalVista Pharmaceuticals (KALV)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$15M | -82.52% |
| 2025 | -$83M | -6.65% |
| 2024 | -$89M | +16.75% |
| 2023 | -$76M | -3.29% |
| 2022 | -$79M | +161.36% |
| 2021 | -$30M | -32.84% |
| 2020 | -$45M | +20.30% |
| 2019 | -$37M | -510.08% |
| 2018 | $9.13M | N/A |
Comparison KalVista Pharmaceuticals (KALV) five years free cash flow CAGR with competitors
KalVista Pharmaceuticals (KALV) five years free cash flow CAGR is 16.60%.